Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) saw strong trading volume on Thursday . 1,995,441 shares traded hands during trading, an increase of 93% from the previous session’s volume of 1,034,818 shares.The stock last traded at $36.27 and had previously closed at $38.11.

Several equities analysts recently weighed in on the stock. Leerink Swann reaffirmed an “outperform” rating and set a $48.00 target price (up from $43.00) on shares of Zeltiq Aesthetics in a research note on Thursday. JPMorgan Chase & Co. reaffirmed a “hold” rating and set a $35.00 target price (up from $27.00) on shares of Zeltiq Aesthetics in a research note on Tuesday. Brean Capital set a $39.00 target price on shares of Zeltiq Aesthetics and gave the company a “buy” rating in a research note on Tuesday. Maxim Group raised their target price on shares of Zeltiq Aesthetics from $40.00 to $48.00 and gave the company a “buy” rating in a research note on Tuesday. Finally, Zacks Investment Research raised shares of Zeltiq Aesthetics from a “sell” rating to a “hold” rating in a research note on Saturday, July 23rd. Three research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $38.33.

The stock has a 50 day moving average of $31.49 and a 200-day moving average of $27.26. The stock has a market capitalization of $1.46 billion and a PE ratio of 55.62.

Zeltiq Aesthetics (NASDAQ:ZLTQ) last posted its earnings results on Monday, August 8th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.07. During the same period in the prior year, the company posted $0.03 EPS. The company had revenue of $89.50 million for the quarter, compared to analysts’ expectations of $79.68 million. Zeltiq Aesthetics’s revenue for the quarter was up 38.9% on a year-over-year basis. Equities research analysts expect that Zeltiq Aesthetics Inc. will post ($0.03) earnings per share for the current fiscal year.

In other news, VP Bradley Hauser sold 3,000 shares of the company’s stock in a transaction on Monday, July 11th. The shares were sold at an average price of $30.02, for a total transaction of $90,060.00. Following the completion of the sale, the vice president now owns 47,184 shares of the company’s stock, valued at $1,416,463.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Mark J. Foley sold 50,000 shares of the company’s stock in a transaction on Tuesday, August 9th. The stock was sold at an average price of $37.89, for a total transaction of $1,894,500.00. Following the sale, the insider now directly owns 365,940 shares of the company’s stock, valued at approximately $13,865,466.60. The disclosure for this sale can be found here.

Several large investors have recently made changes to their positions in ZLTQ. State of Tennessee Treasury Department purchased a new stake in shares of Zeltiq Aesthetics during the fourth quarter worth about $2,853,000. Trexquant Investment LP purchased a new stake in shares of Zeltiq Aesthetics during the fourth quarter worth about $1,640,000. Wells Fargo & Company MN raised its stake in shares of Zeltiq Aesthetics by 765.2% in the fourth quarter. Wells Fargo & Company MN now owns 404,376 shares of the company’s stock worth $11,537,000 after buying an additional 357,636 shares in the last quarter. New York State Common Retirement Fund raised its stake in shares of Zeltiq Aesthetics by 4.3% in the fourth quarter. New York State Common Retirement Fund now owns 41,532 shares of the company’s stock worth $1,185,000 after buying an additional 1,700 shares in the last quarter. Finally, California State Teachers Retirement System raised its stake in shares of Zeltiq Aesthetics by 1.7% in the fourth quarter. California State Teachers Retirement System now owns 59,726 shares of the company’s stock worth $1,704,000 after buying an additional 984 shares in the last quarter.

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.